Acelrx pharmaceuticals announces the closing of its acquisition of lowell therapeutics

Hayward, calif., jan. 10, 2022 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the closing of its acquisition of lowell therapeutics, inc. (lowell).
ACRX Ratings Summary
ACRX Quant Ranking